Lisa Derosa
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 132 publications
First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 01, 2026
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.
Journal: The Lancet. Oncology
Published: December 06, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Journal: Research square
Published: November 24, 2025
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.
Journal: JAMA network open
Published: September 10, 2025
Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.
Journal: Cancer cell
Published: September 01, 2025
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.
Journal: Nature medicine
Published: August 12, 2025
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
Journal: Nature medicine
Published: July 27, 2025
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Journal: Nature medicine
Published: July 24, 2025
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer.
Journal: Oncoimmunology
Published: July 04, 2025
Gut dysbiosis in oncology: a risk factor for immunoresistance.
Journal: Cell research
Published: June 27, 2025
Last Updated: 09/26/2026